Pablo Lapuerta, M.D., has been appointed chief medical officer at Lexicon Pharmaceuticals, Inc. Dr. Lapuerta will be responsible for directing clinical development of drug candidates from Phase II proof-of-concept through Phase III and approval. Dr. Lapuerta has 15 years of pharmaceutical industry experience in a variety of leadership roles in drug development, global medical affairs and outcomes research strategy across multiple therapeutic areas. Most recently, he served as vice president ...